| P2093 | author name string | Rakesh Lodha | |
| | S K Kabra | |
| | Samriti Gupta | |
| P2860 | cites work | Serotype distribution and antimicrobial susceptibility pattern in children≤5years with invasive pneumococcal disease in India - A systematic review | Q38677566 |
| | Antimicrobial resistance and clinical effectiveness of co-trimoxazole versus amoxycillin for pneumonia among children in Pakistan: randomised controlled trial. Pakistan Co-trimoxazole Study Group | Q39472560 |
| | Short-course antibiotic treatment for community-acquired alveolar pneumonia in ambulatory children: a double-blind, randomized, placebo-controlled trial | Q40236494 |
| | Effectiveness of 3-day amoxycillin vs. 5-day co-trimoxazole in the treatment of non-severe pneumonia in children aged 2-59 months of age: a multi-centric open labeled trial | Q40414729 |
| | Efficacy and safety of oral solithromycin versus oral moxifloxacin for treatment of community-acquired bacterial pneumonia: a global, double-blind, multicentre, randomised, active-controlled, non-inferiority trial (SOLITAIRE-ORAL). | Q40801696 |
| | A novel pleuromutilin antibacterial compound, its binding mode and selectivity mechanism | Q41872353 |
| | In vitro activity of tedizolid against gram-positive bacteria in patients with skin and skin structure infections and hospital-acquired pneumonia: a Korean multicenter study | Q42053722 |
| | The definition and classification of pneumonia | Q42338415 |
| | Integrated Analysis of FOCUS 1 and FOCUS 2: Randomized, Doubled‐Blinded, Multicenter Phase 3 Trials of the Efficacy and Safety of Ceftaroline Fosamil versus Ceftriaxone in Patients with Community‐Acquired Pneumonia | Q42822939 |
| | Telavancin activity against Gram-positive bacteria isolated from respiratory tract specimens of patients with nosocomial pneumonia | Q42905478 |
| | Methicillin resistance is not a predictor of severity in community-acquired Staphylococcus aureus necrotizing pneumonia--results of a prospective observational study. | Q43431380 |
| | Clinical efficacy of 3 days versus 5 days of oral amoxicillin for treatment of childhood pneumonia: a multicentre double-blind trial | Q44146950 |
| | An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome | Q44510164 |
| | Oral amoxicillin versus injectable penicillin for severe pneumonia in children aged 3 to 59 months: a randomised multicentre equivalency study | Q45080639 |
| | Chloramphenicol versus benzylpenicillin and gentamicin for the treatment of severe pneumonia in children in Papua New Guinea: a randomised trial | Q45712582 |
| | The ZEPHyR study: a randomized comparison of linezolid and vancomycin for MRSA pneumonia | Q45749888 |
| | Effects of prior effective therapy on the efficacy of daptomycin and ceftriaxone for the treatment of community-acquired pneumonia | Q46620650 |
| | Effectiveness of β-Lactam Monotherapy vs Macrolide Combination Therapy for Children Hospitalized With Pneumonia. | Q47690439 |
| | Investigational drugs in phase I and phase II clinical trials for the treatment of community-acquired pneumonia. | Q47761002 |
| | Antimicrobial therapy of macrolide-resistant Mycoplasma pneumoniae pneumonia in children | Q50047524 |
| | An open, comparative evaluation of amoxycillin and amoxycillin plus clavulanic acid ('Augmentin') in the treatment of bacterial pneumonia in children. | Q50691303 |
| | Pneumonia Due to Drug-Resistant Streptococcus pneumoniae. | Q50953294 |
| | Overview of antimicrobial options for Mycoplasma pneumoniae pneumonia: focus on macrolide resistance. | Q51595534 |
| | Trial of co-trimoxazole versus procaine penicillin G and benzathin penicillin + procaine penicillin G in the treatment of childhood pneumonia. | Q51624526 |
| | Multicenter trial of cefpodoxime proxetil vs. amoxicillin-clavulanate in acute lower respiratory tract infections in childhood. International Study Group. | Q53376504 |
| | TRIAL OF CO-TRIMOXAZOLE VERSUS PROCAINE PENICILLIN WITH AMPICILLIN IN TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN YOUNG GAMBIAN CHILDREN | Q56827595 |
| | Comparison of oral amoxicillin with placebo for the treatment of world health organization-defined nonsevere pneumonia in children aged 2-59 months: a multicenter, double-blind, randomized, placebo-controlled trial in pakistan | Q83049339 |
| | Japanese Guidelines for the Management of Respiratory Infectious Diseases in Children 2007 with focus on pneumonia | Q84291570 |
| | Pneumonia | Q86426461 |
| | Epidemiology and etiology of childhood pneumonia | Q22241278 |
| | The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America | Q22242904 |
| | Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children | Q24186692 |
| | Antibiotics for community-acquired pneumonia in children | Q24202296 |
| | 10 x '20 Progress--development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of America | Q24601746 |
| | The definition of pneumonia, the assessment of severity, and clinical standardization in the Pneumonia Etiology Research for Child Health study | Q26996001 |
| | Global burden of childhood pneumonia and diarrhoea | Q28288886 |
| | Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000 | Q29620061 |
| | Oral Antibiotics for Community acquired Pneumonia with Chest indrawing in Children Aged Below Five Years: A Systematic Review. | Q30249163 |
| | Does 3-day course of oral amoxycillin benefit children of non-severe pneumonia with wheeze: a multicentric randomised controlled trial | Q33330280 |
| | Molecular mechanisms of resistance to commonly used non-betalactam drugs in Streptococcus pneumoniae. | Q33740746 |
| | Antibacterial activity and PK/PD of ceftriaxone against penicillin-resistant Streptococcus pneumoniae and beta-lactamase-negative ampicillin-resistant Haemophilus influenzae isolates from patients with community-acquired pneumonia | Q34584621 |
| | Clinical efficacy of co-trimoxazole versus amoxicillin twice daily for treatment of pneumonia: a randomised controlled clinical trial in Pakistan | Q35567226 |
| | Global in vitro activity of tigecycline and comparator agents: Tigecycline Evaluation and Surveillance Trial 2004-2013. | Q35809588 |
| | Cethromycin versus clarithromycin for community-acquired pneumonia: comparative efficacy and safety outcomes from two double-blinded, randomized, parallel-group, multicenter, multinational noninferiority studies | Q35867451 |
| | Narrow vs broad-spectrum antimicrobial therapy for children hospitalized with pneumonia. | Q35932517 |
| | Zabofloxacin versus moxifloxacin in patients with COPD exacerbation: a multicenter, double-blind, double-dummy, randomized, controlled, Phase III, non-inferiority trial | Q36213054 |
| | Therapeutic efficacy of azithromycin, clarithromycin, minocycline and tosufloxacin against macrolide-resistant and macrolide-sensitive Mycoplasma pneumoniae pneumonia in pediatric patients. | Q36306172 |
| | Chloramphenicol versus ampicillin plus gentamicin for community acquired very severe pneumonia among children aged 2-59 months in low resource settings: multicentre randomised controlled trial (SPEAR study). | Q36359495 |
| | Impact of initial discordant treatment with beta-lactam antibiotics on clinical outcomes in adults with pneumococcal pneumonia: a systematic review | Q36682228 |
| | Epidemiology and etiology of childhood pneumonia in 2010: estimates of incidence, severe morbidity, mortality, underlying risk factors and causative pathogens for 192 countries | Q36978069 |
| | Randomized controlled trial of standard versus double dose cotrimoxazole for childhood pneumonia in Pakistan | Q37056232 |
| | Epidemiology of community-acquired pneumonia and implications for vaccination of children living in developing and newly industrialized countries: A systematic literature review. | Q37264943 |
| | Three day versus five day treatment with amoxicillin for non-severe pneumonia in young children: a multicentre randomised controlled trial | Q37324425 |
| | Randomized, Open-Label Study of the Pharmacokinetics and Safety of Oral and Intravenous Administration of Omadacycline to Healthy Subjects | Q37428710 |
| | Acute community acquired pneumonia in emergency room | Q37871893 |
| | Telavancin for the treatment of hospital-acquired pneumonia: findings from the ATTAIN studies. | Q38048845 |
| | How important is methicillin-resistant Staphylococcus aureus as a cause of community-acquired pneumonia and what is best antimicrobial therapy? | Q38080617 |
| | Treating paediatric community-acquired pneumonia in the era of antimicrobial resistance | Q38170557 |
| | Antibiotic treatment for children hospitalized with community-acquired pneumonia after oral therapy | Q38344368 |
| | A randomized, double-blind, multicenter Phase II study comparing the efficacy and safety of oral nemonoxacin with oral levofloxacin in the treatment of community-acquired pneumonia | Q38397479 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pneumonia | Q12192 |
| P304 | page(s) | 47 | |
| P577 | publication date | 2018-09-20 | |
| P1433 | published in | Current infectious disease reports | Q26842136 |
| P1476 | title | Antimicrobial Therapy in Community-Acquired Pneumonia in Children | |
| P478 | volume | 20 | |